Shlofmitz, Evan
Sosa, Fernando A.
Ali, Ziad A.
Waksman, Ron
Jeremias, Allen
Shlofmitz, Richard
Article History
First Online: 17 June 2019
Compliance with Ethical Standards
:
: F. Sosa is an employee of Abbott Vascular.Z. Ali has served as a consultant to Abbott Vascular, Boston Scientific, Opsens Medical, Cardinal Health, and Canon; has equity/options in Shockwave Medical; and has received research grants from Abbott Vascular, the National Heart, Lung, and Blood Institute, and Cardiovascular Systems Inc.R. Waksman has served on the advisory boards of Abbott Vascular, Amgen, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, and Pi-Cardia Ltd.; as a consultant for Abbott Vascular, Amgen, Biosensors, Biotronik, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, and Pi-Cardia Ltd.; has received grant support from Abbott Vascular, AstraZeneca, Biosensors, Biotronik, Boston Scientific, and Chiesi; has served on the speakers bureaus of AstraZeneca and Chiesi; and has invested in MedAlliance.A. Jeremias has received educational grants from and served as a consultant for Abbott Vascular and Philips; and has served as a consultant for Opsens.All other authors have no conflict of interest to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.